301
Views
3
CrossRef citations to date
0
Altmetric
Drug Evaluation

Bisoprolol for congestive heart failure

, MD & , MD PhD
Pages 293-300 | Published online: 17 Jan 2008
 

Abstract

Background: β-Blockers are a cornerstone in the treatment of systolic heart failure treatment, but not all β-blockers are effective or in this setting. Objective: To define the role of bisoprolol, a highly selective β1-antagonist in congestive heart failure due to systolic dysfunction. Methods: Using the keywords ‘bisoprolol’ and ‘heart failure’ PubMed and BIOSIS databases were searched for information regarding pharmacology and relevant randomised clinical trials. Supplementary publications were acquired by scrutinising reference lists of relevant papers. Additional information was obtained from the FDA website. Conclusion: Bisoprolol is an effective and well-tolerated first-line β-blocker for patients with systolic heart failure. The knowledge is primarily based on study patients with moderate-to-severe heart failure from the three CIBIS trials.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 884.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.